Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 397

    AbbVie to remain cautious on drug pricing, shares fall

    AbbVie to remain cautious on drug pricing, shares fall

    Ruby Khatun Khatun2 Aug 2017 9:15 AM IST
    AbbVie Inc's said it would be cautious with drug pricing, especially for Humira, the world's biggest selling drug, sending its shares down 2 percent,...
    GSK gives up on rare diseases as gene therapy gets two customers

    GSK gives up on rare diseases as gene therapy gets two customers

    Ruby Khatun Khatun2 Aug 2017 9:14 AM IST
    LONDON: GlaxoSmithKline (GSK) is swimming against the tide by getting out of treatments for rare diseases at a time when rivals like Sanofi and Shire...
    Merck says cyber attack halted production, will hurt profits

    Merck says cyber attack halted production, will hurt profits

    Ruby Khatun Khatun1 Aug 2017 9:30 AM IST
    NEW YORK/LAS VEGAS: Drug and vaccine maker Merck & Co Inc said it suffered a worldwide disruption of its operations when it was the victim of an...
    Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine

    Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine

    Ruby Khatun Khatun1 Aug 2017 9:30 AM IST
    Paris, France: Johnson & Johnson announced encouraging first-in-human clinical data for an investigational HIV-1 vaccine regimen in development at...
    Roche leukaemia drug gets FDA breakthrough therapy designation

    Roche leukaemia drug gets FDA breakthrough therapy designation

    Ruby Khatun Khatun1 Aug 2017 9:28 AM IST
    ZURICH: Roche Holding AG's Venclexta has won breakthrough therapy designation in acute myeloid leukaemia (AML) from the U.S. Food and Drug...
    FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death

    FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death

    Ruby Khatun Khatun1 Aug 2017 9:20 AM IST
    The U.S. Food and Drug Administration (FDA) announced a new comprehensive plan for tobacco and nicotine regulation that will serve as a multi-year...
    US House panel spotlights use of FDA rules to slow generic drugs

    US House panel spotlights use of FDA rules to slow generic drugs

    Ruby Khatun Khatun1 Aug 2017 9:20 AM IST
    WASHINGTON: Republican and Democratic lawmakers on Thursday discussed ways to prevent drugmakers from using rules developed to safeguard patients to...
    Canon to enter medical, security and surveillance space

    Canon to enter medical, security and surveillance space

    Ruby Khatun Khatun1 Aug 2017 9:19 AM IST
    New Delhi: Japanese imaging technologies leader Canon is expanding its product portfolio in India with plans to enter into segments, including medical...
    Intec Pharma Granted Patent in Hong Kong for Accordion Pill Carbidopa, Levodopa

    Intec Pharma Granted Patent in Hong Kong for Accordion Pill Carbidopa, Levodopa

    Ruby Khatun Khatun31 July 2017 9:30 AM IST
    JERUSALEM: Intec Pharma Ltd., a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill[TM]...
    Sun Pharma increases stake in Zenotech to 57.56 per cent

    Sun Pharma increases stake in Zenotech to 57.56 per cent

    Ruby Khatun Khatun31 July 2017 9:28 AM IST
    Mumbai: Sun Pharmaceutical (Sun Pharma) Industries has announced that the company has increased its stake in Zenotech Laboratories from 46.85% to...
    AbbVies drug for all types of hepatitis C wins EU approval

    AbbVie's drug for all types of hepatitis C wins EU approval

    Ruby Khatun Khatun31 July 2017 9:25 AM IST
    AbbVie Inc said on Friday it had received European approval to market its drug for treatment of all six major forms of hepatitis C.The company said...
    Data supports safety of Dynavax hepatitis B vaccine: USFDA panel

    Data supports safety of Dynavax hepatitis B vaccine: USFDA panel

    Ruby Khatun Khatun31 July 2017 9:22 AM IST
    Available data supports the safety of Dynavax Technologies Corp's experimental hepatitis B vaccine when administered to adults, a panel of expert...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok